Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Dermata Therapeutics Inc DRMA

Alternate Symbol(s):  DRMAW

Healthcare Biotechnology
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its lead product candidate is XYNGARI, which is in Phase 3 clinical studies for the treatment of moderate-to-severe acne, as well as completed Phase 1b proof of... see more

Current News (NDAQ:DRMA)

Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

ACCESS Newswire December 29, 2025

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

ACCESS Newswire December 24, 2025

A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity

ACCESS Newswire December 4, 2025

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

ACCESS Newswire November 14, 2025

Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office

ACCESS Newswire October 2, 2025

Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025

ACCESS Newswire September 17, 2025

Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments

ACCESS Newswire September 10, 2025

Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

ACCESS Newswire August 13, 2025

Dermata Receives Notice of Grant of Australian Patent for Topical Botulinum Toxin Treatment for Hyperhidrosis

ACCESS Newswire July 8, 2025
View More News ››

Opinion & Analysis (NDAQ:DRMA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:DRMA)

DRMA.....this is so ridiculous !!!!

I saw this early this morning.....the share price pops right after the NR on huge volume... to be honest I thought to myself.....volume...
Iseneschal - March 27, 2025

Buy buddy buy because it's taking off this morning.

This stock is signalling a big uptrend for shareholders today
coolfooldumbguy - March 27, 2025

Dermata Therapeutics (NASDAQ:DRMA) – Leveraging Spongi

Interesting play in the dermatology space. DMT310 looks promising with that 45% reduction in inflammatory lesions from Phase 2b. Phase 3...
MikeTester - January 24, 2025

DRMA...don't be a Bagholder....P.O set up

drma_s3.htm (sec.gov)
Iseneschal - July 24, 2024

DRMA....early a.m runner on no news

$3.40 in PM trading
Iseneschal - July 24, 2024

DRMA ...getting the ST pump....I dare ya!!!

drma_424b3.htm (sec.gov)
Iseneschal - January 30, 2024
View more Bullboard ››

AJA Health and Wellness Inc

AJA Health and Wellness Inc

AJA Health and Wellness Inc. operates a telemedicine platform and full-service travel clinics. The company offers virtual ...
View More »

Podcasts